Table 1 Characteristics of the studies included in the meta-analysis.
Study(year) | Type | Countries | Centers | Number of patients | Gestational age (weeks) | Weight (kg) | VV ECMO (%) | VA ECMO (%) | VV ECMO convert to VA ECMO | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | CDH | MAS | PPHN | Other | |||||||||
van den Hondel D(2013) [16] | Observational | Netherlands | 1 | 136 | 24 | 73 | 0 | 39 | 39.6(37.8-41.4) | 3.4(2.8-3.9) | 0 | 100 | 0 |
Madderom MJ, Gischler SJ(2013) [17] | Observational | Netherlands | 1 | 103(95) | 20 | 46 | 0 | 29 | 40.0(39.0-41.0) | 3.5(3.0-3.8) | NA | NA | NA |
Madderom MJ, Reuser JJ(2013) [18] | Observational | Netherlands | 2 | 135 | 72 | 30 | 0 | 33 | 40.0(34.0-42.0) | 3.1 (2.2-4.8) | 0 | 100 | 0 |
van der Cammen-van Zijp MH(2014) [19] | Observational | Netherlands | 2 | 254 | 137 | 49 | 36 | 32 | 40.0(34.0-43.0) | 3.4 (2.1-4.9) | 9 | 90 | 1 |
Schiller RM(2016) [20] | Observational | Netherlands | 2 | 178 | 97 | 36 | 0 | 45 | 40.0(38.0-42.0) | 3.5(2.9-4.0) | 12 | 87 | 1 |
Toussaint LC(2016) [21] | Observational | Netherlands | 2 | 135 | 76 | 26 | 17 | 16 | 40.0(34.0-43.0) | 3.4 (2.1-5.0) | 3 | 97 | 0 |
Madderom MJ(2016) [22] | Observational | Netherlands | 1 | 34(30) | 21 | 5 | 0 | 8 | 40.0(36.0-43.0) | 3.3(2.2-5.0) | 0 | 100 | 0 |
Engle WA(2017) [23] | Observational | USA | 8 | 146 | 52 | 23 | 22 | 49 | 39.0(36.7-41.3) | 3.4(2.8-4.0) | 27 | 73 | 0 |
Leeuwen L(2018) [24] | Observational | Netherlands | 1 | 35 | 0 | 10 | 0 | 0 | 39.2(36.7-40.7) | 3.1(2.3-3.9) | 0 | 100 | 0 |
Reiterer F(2018) [25] | Observational | Austria | 1 | 43 | 18 | 10 | 2 | 13 | 39.0(32.0-43.0) | 3.4(1.8-4.2) | 39 | 54 | 7 |